Diagnostic performance of a new algorithm combining simple, non-invasive and inexpensive tests for predicting the presence of advanced liver fibrosis in patients with chronic hepatitis B
A new algorithm combining simple, non-invasive, and inexpensive tests demonstrates a good diagnostic value in predicting advanced liver fibrosis in patients with CHB or excluding significant fibrosis. These two rules can aid clinical decision-making by optimizing and limiting the use of more complex complementary and therapeutic examinations, particularly when such resources are rare.
Authors
- Tarik Asselah (ORCID: https://orcid.org/0000-0002-0024-0595)
- Jean Nana
- Céline Vermorel
- Kristina Skaare
- Vincent Leroy (ORCID: https://orcid.org/0000-0003-3464-726X)
- Jean‐Pierre Zarski
- Michael Adler
- Jean Luc Bosson
Institutions
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Hôpital Beaujon (FR)
- Erasmus Hospital (BE)
- Translational Innovation in Medicine and Complexity (FR)
- Institut pour l'avancée des biosciences (FR)
- Hôpital Albert Michallon (FR)
- Université Grenoble Alpes (FR)
Publication Details
- Journal
- BMC Gastroenterology
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1186/s12876-025-03857-4
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.35